Presentation and Status in Health Basket
| Presentation | Basket | Yarpa | Pharmasoft |
|---|---|---|---|
|
Film Coated Tablets 28 x 25 mg |
|
||
|
Film Coated Tablets 28 x 50 mg |
|
||
|
Film Coated Tablets 28 x 100 mg |
|
Dosage
The generally accepted dosage is one tablet once daily.
Please refer to the patient leaflet for the complete information.
Indications
This medicinal product is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes melitus.
Important limitations of use:
This medicinal product should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis as it would not be effective in these settings.
This medicinal product has not been studied in patients with a history of pancreatitis.
It is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using this medicinal product.
Contra-Indications
Hypersensitivity to sitagliptin or to any of the other ingredients.
Please refer to the patient leaflet for the complete information.
Special Precautions
Please refer to the patient leaflet for the complete information.
Side Effects
Please refer to the patient leaflet for the complete information.
Drug interactions
Please refer to the patient leaflet for the complete information.
Pregnancy and Lactation
Please refer to the patient leaflet for the complete information.
Overdose
Please refer to the patient leaflet for the complete information.
